144 studies on Nootropic class curated from PubMed, ClinicalTrials.gov, and EuropePMC. Updated daily.
This research provides experimental substantiation for Semax's role as an immunomodulator, highlighting its potential to counteract the detrimental effects of stress on the immune system. Given that chronic stress is …
This novel iPSC-based platform offers a powerful, human-relevant tool for accelerating neuroprotective drug discovery, potentially reducing the reliance on less predictive animal models and improving the translatabili…
This study highlights the potential of peptide drugs like deltalicin as novel therapeutic agents for managing diabetic dyslipidemia. The finding that deltalicin was more potent than existing treatments suggests it cou…
This research provides compelling evidence for a novel protective role of Semax against stress-induced alterations in gut microbiota, highlighting its potential as a therapeutic agent for maintaining gut health under …
This research highlights the complex and context-dependent role of ACTH4-7-PGP (Semax) in pain modulation, moving beyond a simplistic view of its effects. Understanding this dual action could pave the way for more tar…
This study highlights the potential of Semax as a neuroprotective agent against the detrimental effects of early-life antidepressant exposure, which can lead to long-term behavioral and neurochemical deficits. Given t…
This research highlights PGC-1α activation as a promising therapeutic strategy for mitigating brain damage following ischemic stroke. By enhancing mitochondrial function and reducing oxidative stress, PGC-1α activator…
This research provides strong molecular evidence for Semax's neuroprotective properties, specifically its ability to mitigate the detrimental inflammatory response after ischemic stroke. By suppressing the mRNA expres…
This study provides critical molecular evidence supporting ACTH's neuroprotective role by elucidating its impact on the brain's protein landscape. The upregulation of neurotrophic factors like BDNF and downregulation …
This research highlights that melanocortin derivatives show substantial promise as potential therapeutic agents for mitigating the impact of stress and treating stress-related disorders. By actively normalizing gene e…
This study successfully establishes a robust and reproducible mouse model for nigrostriatal dopaminergic axonal degeneration, providing a critical tool for preclinical drug discovery. This model offers a high-throughp…
This study highlights Semax's potential as a therapeutic agent for Alzheimer's disease by directly targeting copper-mediated Abeta toxicity, a key pathway in neurodegeneration. Its ability to interfere with a critical…
This research underscores the transformative potential of 3-D Shear Wave Elastography as a superior, non-invasive diagnostic tool for thyroid nodules. The significantly improved accuracy, sensitivity, and specificity …
This research is significant because it suggests that complex physiotherapeutic neurostimulation could offer a novel, non-invasive therapeutic strategy for a range of optical neuropathies, conditions for which effecti…
This study provides compelling evidence that synthetic corticotropins can directly and indirectly modulate the GABA-receptor system, offering a novel therapeutic avenue for stress-related neuropsychiatric disorders. T…
This study's findings are significant because they suggest synthetic ACTH peptides could be a novel therapeutic strategy to mitigate detrimental neuroinflammation after stroke. By shifting the immune response towards …
These findings provide critical insights into the molecular mechanisms underlying the neuroprotective and cognitive-enhancing effects of synthetic ACTH-like peptides. The significant upregulation of genes vital for ne…
These findings are significant as they identify Semax and Melanotan II as promising candidates for treating stress-related disorders and depression, potentially offering a new class of neuroactive peptides. Their abil…
This breakthrough represents a significant advancement in multifunctional material design, offering a robust solution for diverse high-tech applications. The ability to combine high EMI shielding with excellent mechan…
This research highlights the significant neuroprotective and gene-regulatory potential of ACTH-like peptides in the context of ischemic stroke. By restoring a vast majority of disrupted gene expression profiles, these…
This research highlights Semax's potential as a neuroprotective agent against key aspects of Alzheimer's disease (AD) pathology. By targeting metal-induced oxidative stress, Semax offers a novel therapeutic strategy t…
This research uncovers a novel mechanism by which Semax peptide promotes recovery after spinal cord injury, specifically through targeting the Oprm1 gene and enhancing deubiquitination, a process crucial for protein s…
These findings provide crucial insights into the cellular targets and initial interaction dynamics of Semax within the brain, particularly highlighting its specific impact on hippocampal neurons. The observed increase…
This research highlights the potential of ACTH4-10Pro8-Gly9-Pro10 to actively promote an anti-inflammatory response in the acute phase of spinal cord injury, which is critical for limiting secondary damage. By boostin…
This study provides compelling and quantitative evidence that Selank possesses the capability to effectively compensate for the long-lasting negative effects of antenatal hypoxia on both integrative brain activity and…
This research highlights Selank's potential as a novel anxiolytic or antipsychotic agent that can modulate dopamine system activity without directly binding to dopamine receptors, potentially offering a therapeutic pr…
This research provides compelling evidence for the anti-ulcer properties of Selank, suggesting its potential beyond its known anxiolytic (anti-anxiety) effects. The fact that its metabolites also contribute to this pr…
This study provides compelling evidence that Selank holds significant promise as a therapeutic agent for addressing the long-term neurological consequences of antenatal hypoxia. The ability to correct deficits in sens…
This research highlights Selank's potential as a novel therapeutic agent for Generalized Anxiety Disorder and neurasthenia, offering a dual benefit of anxiety reduction alongside anti-fatigue and psychostimulant effec…
This research highlights Selank's significant potential as a neuroprotective and cognitive-enhancing agent, particularly in conditions involving noradrenergic system dysfunction. Given that cognitive deficits are a ha…
These findings suggest that Selank possesses unique immunomodulatory properties, acting as a novel regulator of the immune response. This dual effect on IL-6 gene expression and protein concentration, alongside its im…
These findings are highly significant as they demonstrate Selank's broad efficacy against both genetically-based and situation-provoked symptoms of depression and anxiety. Its ability to act as an anxiolytic and antid…
This research highlights the significant potential of Selank as a therapeutic agent for cognitive impairments resulting from early-life neurological damage. The ability of Selank to restore complex cognitive functions…
This research provides critical and actionable insights into the pharmacokinetics of glyprolines, underscoring that the chosen route of administration profoundly dictates their bioavailability to key target organs suc…
This research provides compelling evidence for Selank's potential as a broad-spectrum therapeutic agent for psychoemotional disturbances. Its ability to induce long-term compensation of both behavioral and cognitive d…
This research provides crucial insights into the pharmacogenomic variability of peptide therapeutics, demonstrating how genetic background can profoundly influence drug efficacy and mechanism of action. Understanding …
This study provides compelling evidence that MIF and Selank possess significant neuroprotective and anti-inflammatory properties in the context of hemorrhagic stroke. The observed improvements in neurological function…
This research underscores selank's potential as a promising therapeutic agent for conditions characterized by decreased serotonin metabolism. The observed ability of selank to rapidly enhance 5-HT metabolism in the br…
These findings highlight Selank's potential as a novel antiviral agent, particularly for influenza prevention. The ability of Selank to modulate the immune response by selectively upregulating IFN-alpha suggests a tar…
This research provides compelling evidence that Selank acts as a potent nootropic agent, significantly enhancing long-term memory stability. The observed modulation of serotonin metabolism offers a plausible mechanism…
This research provides compelling evidence that altered long-distance neural communication, specifically within the gamma frequency band, is a persistent neurobiological feature of bipolar disorder, even when patients…
This research provides compelling evidence that Selank possesses potent immunomodulatory properties, extending beyond its known neurological effects, by directly influencing the transcriptional activity of key inflamm…
This research significantly advances our understanding of Selank's mechanism of action, particularly its immunomodulating effects at the genetic level. Identifying Gly-Pro as a key pharmacophor for these effects opens…
This study provides a crucial mechanistic understanding of how Noopept and Selank exert their nootropic and anxiolytic effects by enhancing inhibitory neurotransmission in the hippocampus. By demonstrating that these …
This research identifies the enkephalin-opioid system as a critical modulator of Selank's anxiolytic actions, revealing a new dimension to its mechanism within the central nervous system (CNS). Understanding this intr…
This research provides a potential biochemical mechanism for Selank's known anxiolytic and nootropic effects. By modulating the activity of carboxypeptidases, Selank could directly influence the production and availab…
This research highlights Selank's potential as a promising therapeutic agent for cognitive enhancement and the treatment of memory impairment. Given its ability to counteract deficits caused by protein synthesis inhib…